Research graph
References from Plant-Derived Flavonoids Ameliorate Diabetic Nephropathy: Molecular Mechanisms and Therapeutic Potential. Local targets link to admitted publications; unresolved targets remain external evidence.
Deubiquitinating enzymes as therapeutic targets in diabetic nephropathy
10.1016/j.tips.2025.07.015 · 2026 · External reference
Epidemiological research on diabetic nephropathy at global, regional, and national levels from 1990 to 2021: an analysis derived from the global burden of disease 2021 study
2025 · External reference
The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases
10.1186/s12967-019-2016-y · 2019 · External reference
Temporal trends in the prevalence of diabetic kidney disease in the United States
10.1001/jama.2011.861 · 2011 · External reference
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
10.1016/j.diabres.2021.109119 · 2022 · External reference
Diabetic kidney disease back in focus: management field guide for health care professionals in the 21st century
10.1016/j.mayocp.2022.05.003 · 2022 · External reference
Pathologic classification of diabetic nephropathy
10.1681/asn.2010010010 · 2010 · External reference
Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy
10.2337/db07-0019 · 2007 · External reference
Naringin ameliorates diabetic nephropathy by inhibiting NADPH oxidase 4
10.1016/j.ejphar.2017.04.006 · 2017 · External reference
An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines
10.1111/dom.14007 · 2020 · External reference
Diabetic nephropathy: diagnosis, prevention, and treatment
10.2337/diacare.28.1.164 · 2005 · External reference
Update on Diabetic Nephropathy: Core Curriculum 2018
10.1053/j.ajkd.2017.10.026 · 2018 · External reference
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
10.1038/s41581-021-00393-8 · 2021 · External reference
Mechanisms of diabetic kidney disease and established and emerging treatments
10.1038/s41574-025-01171-3 · 2026 · External reference
Molecular mechanisms and therapeutic targets for diabetic kidney disease
10.1016/j.kint.2022.05.012 · 2022 · External reference
Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome
10.1016/j.phymed.2018.01.026 · 2018 · External reference
Phillygenin improves diabetic nephropathy by inhibiting inflammation and apoptosis via regulating TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling pathways
10.1016/j.phymed.2024.156314 · 2025 · External reference
Paeonol ameliorates diabetic nephropathy by promoting TFEB-mediated lysosome biogenesis and lipophagy
10.1016/j.phymed.2025.156901 · 2025 · External reference
The natural compound stachyose targets SGLT2-mediated metabolic reprogramming to ameliorate diabetic kidney disease
10.1016/j.phymed.2025.157182 · 2025 · External reference
Flavonoids on diabetic nephropathy: advances and therapeutic opportunities
10.1186/s13020-021-00485-4 · 2021 · External reference
Kaempferol attenuates diabetic nephropathy in streptozotocin-induced diabetic rats by a hypoglycaemic effect and concomitant activation of the Nrf-2/Ho-1/antioxidants axis
10.1080/13813455.2021.1890129 · 2023 · External reference
Quercetin ameliorates podocyte injury via inhibition of oxidative stress and the TGF-β1/Smad pathway in DN rats
10.1039/c8ra07935h · 2018 · External reference
Wogonin Alleviates Streptozotocin-stimulated Diabetic Nephropathy through its Antidiabetic, Antidyslipidemic, and Antioxidative Effects in Rats
10.1177/09731296241274880 · 2025 · External reference
EGCG targeting Notch to attenuate renal fibrosis via inhibition of TGFβ/Smad3 signaling pathway activation in streptozotocin-induced diabetic mice
10.1039/d0fo01542c · 2020 · External reference
Puerarin alleviates the high glucose-induced oxidative stress via the RAGE/PKC/NOX4 axis in renal mesangial cells
10.2131/jts.49.497 · 2024 · External reference
Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway
10.1016/j.jpha.2024.01.014 · 2024 · External reference
Molecular insights of diabetic nephropathy and chemical constituents-based treatment approach
10.1007/s11101-025-10068-y · 2025 · External reference
Therapeutic potential of natural medicines in diabetic kidney disease: restoring lipid homeostasis via lipophagy modulation
10.3389/fphar.2025.1665339 · 2025 · External reference
A glimpse of various pathogenetic mechanisms of diabetic nephropathy
10.1146/annurev.pathol.4.110807.092150 · 2011 · External reference
Glomerular hemodynamics in experimental diabetes mellitus
10.1038/ki.1981.33 · 1981 · External reference
Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment
10.1681/asn.2016060666 · 2017 · External reference
Exaggerated impact of ATP-sensitive K(+) channels on afferent arteriolar diameter in diabetes mellitus
10.1681/asn.v1171199 · 2000 · External reference
Activation of the renin-angiotensin system within podocytes in diabetes
10.1038/sj.ki.5002195 · 2007 · External reference
A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli
10.1152/ajprenal.00159.2003 · 2005 · External reference
Molecular pathways that drive diabetic kidney disease
10.1172/jci165654 · 2023 · External reference
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
10.1038/s41581-018-0001-y · 2018 · External reference
Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy
10.1007/s11154-017-9422-3 · 2017 · External reference
Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs
10.1016/j.phrs.2019.01.043 · 2019 · External reference
Protein UHRF1-mediated dual dysregulation of molecular chaperone GRP78 induces endoplasmic reticulum stress and aggravates diabetic nephropathy
10.1016/j.kint.2025.07.023 · 2025 · External reference
Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?
10.1111/bph.12503 · 2014 · External reference
Flavonoids as Aglycones in Retaining Glycosidase-Catalyzed Reactions: Prospects for Green Chemistry
10.1021/acs.jafc.3c04389 · 2023 · External reference
Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity
10.1016/j.foodchem.2022.132531 · 2022 · External reference
Naturally occurring chalcones and their biological activities
10.1007/s11101-014-9387-8 · 2016 · External reference
Wound healing properties of flavonoids: A systematic review highlighting the mechanisms of action
10.1016/j.phymed.2021.153636 · 2021 · External reference
Innate immunity in diabetic kidney disease
10.1038/s41581-019-0234-4 · 2020 · External reference
Astilbin Inhibits High Glucose-Induced Inflammation and Extracellular Matrix Accumulation by Suppressing the TLR4/MyD88/NF-κB Pathway in Rat Glomerular Mesangial Cells
10.3389/fphar.2018.01187 · 2018 · External reference
Kaempferol attenuates streptozotocin-induced diabetic nephropathy by downregulating TRAF6 expression: The role of TRAF6 in diabetic nephropathy
10.1016/j.jep.2020.113553 · 2021 · External reference
(+)-Catechin ameliorates diabetic nephropathy injury by inhibiting endoplasmic reticulum stress-related NLRP3-mediated inflammation
10.1039/d3fo05400d · 2024 · External reference
Puerarin reduces diabetic nephropathy-induced podocyte pyroptosis by modulating the SIRT1/NLRP3/caspase-1 pathway
10.1016/j.mce.2024.112409 · 2025 · External reference
Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome
10.1016/j.phymed.2018.01.026 · 2018 · External reference
Isoquercitrin Alleviates Diabetic Nephropathy by Inhibiting STAT3 Phosphorylation and Dimerization
10.1002/advs.202414587 · 2025 · External reference
Isoliquiritigenin Alleviates Diabetic Kidney Disease via Oxidative Stress and the TLR4/NF-κB/NLRP3 Inflammasome Pathway
10.1002/mnfr.202400215 · 2024 · External reference
Wogonin upregulates SOCS3 to alleviate the injury in Diabetic Nephropathy by inhibiting TLR4-mediated JAK/STAT/AIM2 signaling pathway
10.1186/s10020-024-00845-4 · 2024 · External reference
Baicalin alleviates lipid metabolism disorders in diabetic kidney disease via targeting FKBP51
10.1016/j.phymed.2025.156473 · 2025 · External reference
Isoliquiritigenin prevents hyperglycemia-induced renal injuries by inhibiting inflammation and oxidative stress via SIRT1-dependent mechanism
10.1038/s41419-020-03260-9 · 2020 · External reference
Baicalin Alleviates Oxidative Stress and Inflammation in Diabetic Nephropathy via Nrf2 and MAPK Signaling Pathway
10.2147/dddt.s319260 · 2021 · External reference
Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways
10.1152/ajprenal.00393.2016 · 2017 · External reference
(-)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling
10.1039/d0fo01805h · 2020 · External reference
Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease
10.3390/antiox13040455 · 2024 · External reference
Role of Nrf2 dysfunction in the pathogenesis of diabetic nephropathy: Therapeutic prospect of epigallocatechin-3-gallate
10.1016/j.freeradbiomed.2020.07.037 · 2020 · External reference
Ampelopsin inhibits high glucose-induced extracellular matrix accumulation and oxidative stress in mesangial cells through activating the Nrf2/HO-1 pathway
10.1002/ptr.6668 · 2020 · External reference
Eriodictyol inhibits high glucose-induced extracellular matrix accumulation, oxidative stress, and inflammation in human glomerular mesangial cells
10.1002/ptr.6463 · 2019 · External reference
Wogonoside ameliorates oxidative damage in tubular epithelial cells of diabetic nephropathy by modulating the HNF4A-NRF2 axis
10.1016/j.intimp.2025.114481 · 2025 · External reference
Formononetin Activates the Nrf2/ARE Signaling Pathway Via Sirt1 to Improve Diabetic Renal Fibrosis
2020 · External reference
Therapeutic potential of digitoflavone on diabetic nephropathy: nuclear factor erythroid 2-related factor 2-dependent anti-oxidant and anti-inflammatory effect
2015 · External reference
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
10.1038/s41581-019-0135-6 · 2019 · External reference
Isoliquiritigenin entails blockade of TGF-beta1-SMAD signaling for retarding high glucose-induced mesangial matrix accumulation
10.1021/jf9040723 · 2010 · External reference
Scutellarin ameliorates diabetic nephropathy via TGF-β1 signaling pathway
10.1007/s13659-024-00446-y · 2024 · External reference
Cyanidin-3-glucoside from Black Rice Ameliorates Diabetic Nephropathy via Reducing Blood Glucose, Suppressing Oxidative Stress and Inflammation, and Regulating Transforming Growth Factor β1/Smad Expression
10.1021/acs.jafc.0c00680 · 2020 · External reference
Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-κB and TGF-β1/Smad3 Signaling Pathways in Diabetic Nephropathy
10.2147/dddt.s274256 · 2020 · External reference
Natural products targeting TGF-β/Smad signaling in renal fibrosis: Multiomics-based novel molecular mechanisms and therapeutic strategies
10.1016/j.phymed.2025.157496 · 2025 · External reference
Organ Fibrosis and Autoimmunity: The Role of Inflammation in TGFβ-Dependent EMT
10.3390/biom11020310 · 2021 · External reference
Molecular mechanisms of epithelial-mesenchymal transition
10.1038/nrm3758 · 2014 · External reference
(+)-Catechins Play a Protective Role in Diabetic Kidney Disease by Alleviating EMT through Multiple Pathways
10.1002/mnfr.202400387 · 2024 · External reference
Tangeretin Ameliorates Glucose-Induced Podocyte Injury through Blocking Epithelial to Mesenchymal Transition Caused by Oxidative Stress and Hypoxia
10.3390/ijms21228577 · 2020 · External reference
Quercetin prevents the USP22-Snail1 signaling pathway to ameliorate diabetic tubulointerstitial fibrosis
10.1039/d4fo03564j · 2024 · External reference
Impact of EGCG Supplementation on the Progression of Diabetic Nephropathy in Rats: An Insight into Fibrosis and Apoptosis
10.1021/acs.jafc.7b03301 · 2017 · External reference
Quercetin Attenuates Podocyte Apoptosis of Diabetic Nephropathy Through Targeting EGFR Signaling
2021 · External reference
Quercetin prevented diabetic nephropathy by inhibiting renal tubular epithelial cell apoptosis via the PI3K/AKT pathway
10.1002/ptr.8227 · 2024 · External reference
Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease
10.1038/s41401-021-00721-5 · 2022 · External reference
Kaempferol attenuated diabetic nephropathy by reducing apoptosis and promoting autophagy through AMPK/mTOR pathways
2022 · External reference
Icariin modulates mitochondrial function and apoptosis in high glucose-induced glomerular podocytes through G protein-coupled estrogen receptors
10.1016/j.mce.2018.01.014 · 2018 · External reference
Endoplasmic reticulum stress and lipids in health and diseases
10.1016/j.plipres.2022.101198 · 2023 · External reference
The role of endoplasmic reticulum stress in human pathology
10.1146/annurev-pathol-012513-104649 · 2015 · External reference
Endoplasmic reticulum stress in diabetic kidney disease: adaptation and apoptosis after three UPR pathways
10.1007/s10495-023-01858-w · 2023 · External reference
Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2α-ATF-CHOP pathway in diabetic mice
10.1038/aps.2017.30 · 2017 · External reference
Diosmin mitigates high glucose-induced endoplasmic reticulum stress through PI3K/AKT pathway in HK-2 cells
10.1186/s12906-022-03597-y · 2022 · External reference
Icariin Attenuation of Diabetic Kidney Disease Through Inhibition of Endoplasmic Reticulum Stress via G Protein-Coupled Estrogen Receptors
10.1166/jbn.2022.3242 · 2022 · External reference
The cell biology of ferroptosis
10.1038/s41580-024-00703-5 · 2024 · External reference
Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities
10.7150/ijbs.81892 · 2023 · External reference
Intermodulation of endoplasmic reticulum stress and ferroptosis in diabetic nephropathy: molecular mechanisms and therapeutic potentials
10.1007/s10495-025-02195-w · 2025 · External reference
Calycosin plays a protective role in diabetic kidney disease through the regulation of ferroptosis
10.1080/13880209.2022.2067572 · 2022 · External reference
In silico prediction and experimental validation to reveal the protective mechanism of Puerarin against excessive extracellular matrix accumulation through inhibiting ferroptosis in diabetic nephropathy
2024 · External reference
Vitexin ameliorated diabetic nephropathy via suppressing GPX4-mediated ferroptosis
10.1016/j.ejphar.2023.175787 · 2023 · External reference
Naringenin Inhibits Ferroptosis in Renal Tubular Epithelial Cells of Diabetic Nephropathy Through SIRT1/FOXO3a Signaling Pathway
10.1002/ddr.70044 · 2025 · External reference
Quercetin Ameliorates Diabetic Kidney Injury by Inhibiting Ferroptosis via Activating Nrf2/HO-1 Signaling Pathway
10.1142/s0192415x23500465 · 2023 · External reference
Quercetin improves diabetic kidney disease by inhibiting ferroptosis and regulating the Nrf2 in streptozotocin-induced diabetic rats
10.1080/0886022x.2024.2327495 · 2024 · External reference
Fisetin Ameliorates Diabetic Nephropathy-Induced Podocyte Injury by Modulating Nrf2/HO-1/GPX4 Signaling Pathway
10.1155/2023/9331546 · 2023 · External reference
Autophagy in Its (Proper) Context: Molecular Basis, Biological Relevance, Pharmacological Modulation, and Lifestyle Medicine
10.7150/ijbs.95122 · 2024 · External reference
Autophagy in kidney homeostasis and disease
10.1038/s41581-020-0309-2 · 2020 · External reference
Nephroprotective Effects of Formononetin in Diabetic Kidney Disease: Mechanistic Insights and Therapeutic Potential
10.1142/s0192415x25500843 · 2025 · External reference
Wogonin Alleviates Kidney Tubular Epithelial Injury in Diabetic Nephropathy by Inhibiting PI3K/Akt/NF-κB Signaling Pathways
10.2147/dddt.s310882 · 2021 · External reference
Rutin alleviates EndMT by restoring autophagy through inhibiting HDAC1 via PI3K/AKT/mTOR pathway in diabetic kidney disease
10.1016/j.phymed.2023.154700 · 2023 · External reference
Kaempferol improves mitochondrial homeostasis via mitochondrial dynamics and mitophagy in diabetic kidney disease
10.1016/j.intimp.2025.115121 · 2025 · External reference
Dietary microRNA-A Novel Functional Component of Food
10.1093/advances/nmy127 · 2019 · External reference
MicroRNA
10.1016/j.jaci.2017.08.034 · 2018 · External reference
MicroRNA-Based Diagnosis and Therapy
10.3390/ijms23137167 · 2022 · External reference
Diabetic nephropathy--emerging epigenetic mechanisms
10.1038/nrneph.2014.116 · 2014 · External reference
MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets
10.1111/nyas.12758 · 2015 · External reference
MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy
2020 · External reference
Dihydromyricetin promotes autophagy and attenuates renal interstitial fibrosis by regulating miR-155-5p/PTEN signaling in diabetic nephropathy
2020 · External reference
Hyperoside ameliorates diabetic nephropathy induced by STZ via targeting the miR-499-5p/APC axis
10.1016/j.jphs.2021.02.005 · 2021 · External reference
Quercetin attenuates the proliferation, inflammation, and oxidative stress of high glucose-induced human mesangial cells by regulating the miR-485-5p/YAP1 pathway
10.1177/20587384211066440 · 2022 · External reference
Icariin Ameliorates Diabetic Renal Tubulointerstitial Fibrosis by Restoring Autophagy via Regulation of the miR-192-5p/GLP-1R Pathway
10.3389/fphar.2021.720387 · 2021 · External reference
Oxidative stress as a culprit in diabetic kidney disease
10.1016/j.lfs.2023.121661 · 2023 · External reference
Advances in understanding the NLRP3 inflammasome-mediated mechanisms and therapeutic targets in diabetic nephropathy
10.3892/ijmm.2026.5847 · 2026 · External reference
Mitigation of ROS-triggered endoplasmic reticulum stress by upregulating Nrf2 retards diabetic nephropathy
10.1016/j.bbrc.2024.149972 · 2024 · External reference
Redox regulation in diabetic kidney disease
10.1152/ajprenal.00047.2023 · 2023 · External reference
Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy
10.1186/s10020-024-01020-5 · 2024 · External reference
Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy
10.1155/2018/1875870 · 2018 · External reference
NAC alleviative ferroptosis in diabetic nephropathy via maintaining mitochondrial redox homeostasis through activating SIRT3-SOD2/Gpx4 pathway
10.1016/j.freeradbiomed.2022.05.024 · 2022 · External reference
Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease
10.3390/antiox13040455 · 2024 · External reference
Molecular pathways and emerging therapeutic targets in the pathogenesis of diabetic kidney disease
10.3389/fphys.2026.1747053 · 2026 · External reference
The New Biology of Diabetic Kidney Disease-Mechanisms and Therapeutic Implications
10.1210/endrev/bnz010 · 2020 · External reference
Autophagy and mitophagy: physiological implications in kidney inflammation and diseases
10.1152/ajprenal.00012.2023 · 2023 · External reference
Autophagy and Mitophagy in Diabetic Kidney Disease-A Literature Review
10.3390/ijms26020806 · 2025 · External reference
MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets
10.1111/nyas.12758 · 2015 · External reference
The Role of MicroRNA in the Pathogenesis of Diabetic Nephropathy
10.3390/ijms24076214 · 2023 · External reference
miR-374a Regulates Inflammatory Response in Diabetic Nephropathy by Targeting MCP-1 Expression
10.3389/fphar.2018.00900 · 2018 · External reference
Promising renoprotective effect of gold nanoparticles and dapagliflozin in diabetic nephropathy via targeting miR-192 and miR-21
10.1002/jbt.23430 · 2023 · External reference
Absorption, metabolism and bioavailability of flavonoids: a review
10.1080/10408398.2021.1917508 · 2022 · External reference
Polyphenols: food sources and bioavailability
10.1093/ajcn/79.5.727 · 2004 · External reference
Absorption, metabolism, and excretion of green tea flavan-3-ols in humans with an ileostomy
10.1002/mnfr.200900194 · 2010 · External reference
Bioavailability and metabolism of orange juice flavanones in humans: Impact of a full-fat yogurt
10.1021/jf801974v · 2008 · External reference
Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: A 13C-tracer study
10.3945/ajcn.112.049247 · 2013 · External reference
Absorption, distribution, metabolism and excretion of apigenin and its glycosides in healthy male adults
10.1016/j.freeradbiomed.2022.04.007 · 2022 · External reference
Enhancement of bioavailability and bioactivity of diet-derived flavonoids by application of nanotechnology: a review
10.1080/10408398.2021.1947772 · 2023 · External reference
Calycosin-loaded nanoliposomes as potential nanoplatforms for treatment of diabetic nephropathy through regulation of mitochondrial respiratory function
10.1186/s12951-021-00917-1 · 2021 · External reference
Reno protective potential of taxifolin liposomes modified by chitosan in diabetic mice
10.1016/j.ijbiomac.2025.141464 · 2025 · External reference
Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium
10.2147/ijn.s146978 · 2017 · External reference
Kidney-targeted baicalin-lysozyme conjugate ameliorates renal fibrosis in rats with diabetic nephropathy induced by streptozotocin
10.1186/s12882-020-01833-6 · 2020 · External reference
Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin
10.1007/s13318-018-0517-3 · 2019 · External reference
Association between dietary intake of flavonoid and bone mineral density in middle aged and elderly Chinese women and men
10.1007/s00198-014-2763-9 · 2014 · External reference
Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients
10.3945/jn.114.205674 · 2015 · External reference
Quercetin reduces blood pressure in hypertensive subjects
10.1093/jn/137.11.2405 · 2007 · External reference
Dose translation from animal to human studies revisited
10.1096/fj.07-9574lsf · 2008 · External reference
Bioavailability of Food Polyphenols: Current State of Knowledge
10.1146/annurev-food-060721-023817 · 2025 · External reference
The bioavailability, transport, and bioactivity of dietary flavonoids: A review from a historical perspective
10.1111/1541-4337.12351 · 2018 · External reference
A look beyond dietary (poly)phenols: The low molecular weight phenolic metabolites and their concentrations in human circulation
10.1111/1541-4337.13006 · 2022 · External reference
The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids
10.3945/ajcn.116.136051 · 2017 · External reference
Factors driving the inter-individual variability in the metabolism and bioavailability of (poly)phenolic metabolites: A systematic review of human studies
10.1016/j.redox.2024.103095 · 2024 · External reference
Interactions between dietary flavonoids and the gut microbiome: A comprehensive review
10.1017/s0007114521003627 · 2022 · External reference
Flavonoids for gastrointestinal tract local and associated systemic effects: A review of clinical trials and future perspectives
10.1016/j.jare.2025.01.014 · 2025 · External reference
Dietary flavonoid aglycones and their glycosides: Which show better biological significance?
2017 · External reference
The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility
10.3390/nu8020078 · 2016 · External reference
Bacterial species involved in the conversion of dietary flavonoids in the human gut
10.1080/19490976.2016.1158395 · 2016 · External reference
The occurrence, fate and biological activities of C-glycosyl flavonoids in the human diet
10.1080/10408398.2012.694497 · 2015 · External reference
Metabolism of rutin and poncirin by human intestinal microbiota and cloning of their metabolizing α-L-rhamnosidase from Bifidobacterium dentium
10.4014/jmb.1404.04060 · 2015 · External reference
Bioconversion of anthocyanin glycosides by bifidobacteria and Lactobacillus
10.1016/j.foodres.2009.07.026 · 2009 · External reference
Deglycosylation of puerarin and other aromatic C-glucosides by a newly isolated human intestinal bacterium
10.1111/j.1462-2920.2010.02352.x · 2011 · External reference
Isolation and characterization of human intestinal Enterococcus avium EFEL009 converting rutin to quercetin
10.1111/lam.12512 · 2016 · External reference
Flavonoids and gut health
10.1016/j.copbio.2019.12.018 · 2020 · External reference
Flavonoid bioavailability and attempts for bioavailability enhancement
10.3390/nu5093367 · 2013 · External reference
Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay
10.1016/j.phrs.2024.107452 · 2024 · External reference
Unique roles in health promotion of dietary flavonoids through gut microbiota regulation: Current understanding and future perspectives
10.1016/j.foodchem.2022.133959 · 2023 · External reference
The interaction between flavonoids and intestinal microbes: A review
10.3390/foods12020320 · 2023 · External reference
Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the "gut-kidney axis"
10.1016/j.phymed.2023.155129 · 2023 · External reference
Gut microbiota and its metabolites - molecular mechanisms and management strategies in diabetic kidney disease
10.3389/fimmu.2023.1124704 · 2023 · External reference
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
10.1016/j.ebiom.2019.08.069 · 2019 · External reference
